News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | US-Iran Talks Near Agreement; Robinhood Plans $1.5B Stock Buyback; PDD Reports Earnings Today (March 25, 2026)2Circle’s European Expansion: Will Adaptable Regulations Release $316B in Stablecoin Transactions?3Bitcoin Remains Steady at $70K as Gold Plummets: Interpreting Market Movements Amid Geopolitical Turmoil
Visa (V) Options Display Bullish Bias at $320 Call — Here’s a Strategy for the RSI Oversold Scenario
101 finance·2026/03/20 18:15
Janus Living Surges 17.5% in Volatile Session — What's Fueling the Surge?
101 finance·2026/03/20 18:15
Costco (COST) Options Signal Key Resistance Battle – Focus on $940 Puts and $1020 Calls for Friday's Moves
101 finance·2026/03/20 18:15
Super Micro (SMCI) Drops 29.9% Amid Legal Issues, Market Anxiety Grows While Competitors Surge
101 finance·2026/03/20 18:15
Vertiv Drops 2.84% as Sector Faces Instability and Options Trading Swings: What’s Happening with VRT?
101 finance·2026/03/20 18:15
This $91 Million Investment Reflects Strong Confidence in a Biotech Firm Awaiting an FDA Ruling This Year
101 finance·2026/03/20 18:15
Flash
20:51
The Nasdaq Biotechnology Index closed up more than 2.6%, outperforming the major US stock market indices.Constituent stocks saw Sarepta Therapeutics close up by 34.98%, Summit Therapeutics Plc. increased by 15.53%, Enliven Therapeutics rose by 14.06%, Upstream Bio gained 12.07%, Taysha Gene was up 10.90%, Gossamer Bio rose by 10.61%, and Oruka Therapeutics increased by 9.80%. In contrast, Aardvark Therapeutics closed down 6.10%, ADMA Biologics fell by 15.23%, Anavex Life Sciences dropped 34.61%, and Maze Therapeutics fell 35.24%.
20:50
After challenging the board of directors, Banca Monte dei Paschi di Siena dismissed Lovaglio as CEO.The board of directors has revoked Lovaglio’s CEO powers and suspended his position as general manager because he joined the rival camp’s candidate list in the election, attempting to retain his original post. The bank stated that it reserves the right to make any appropriate assessments regarding the PLT candidate list, including whether it complies with applicable corporate and regulatory requirements. Expand
20:43
The United States introduces a new reactor licensing regime to simplify nuclear power plant construction.According to a statement released on March 25, the process called “Part 53” is the agency’s first new framework for approving reactors since 1989, and is part of the broader plan to expand nuclear power generation in the United States. Expand
News